Covalent linkage of myristic acid to the Nterminal glycine residue of Pr55gag, the precursor of the major structural proteins of human immunodeficiency virus 1 (HIV-1), facilitates an essential step in virus assembly and propagation. Substitution of the myristoyl-acceptor glycine with ala-
The covalent attachment of long-chain fatty acids to select subsets of eukaryotic cellular proteins and viral polypeptides confers a change in hydrophobicity that may be important in defining protein quaternary structure, directing intracellular trafficking and signal transduction, and/or in specific protein-protein or protein-lipid interactions at the plasma membrane. The specific fatty acid and its distinct mode of attachment probably influence the unique biochemical function served by each acylated protein (1) (2) (3) (4) (5) .
The most thoroughly studied acyl proteins have been virus-related polypeptides because of their high level of expression in infected cells. Schmidt and Schlesinger (6) were first to describe the attachment of fatty acid to the envelope glycoproteins of vesicular stomatitis and Sindbis viruses and to suggest an association of this type of protein modification with virus assembly and propagation (7) . Subsequently, the structural proteins of nonenveloped viruses have also been shown to contain covalently bound fatty acid. The capsid protein VP4 and its precursors in picornaviruses are myristoylated (8) (9) (10) (11) . The position of the myristate moiety at the interface between protein subunits in poliovirus suggests that it may play a role in virus capsid assembly (12) . The structural proteins of polyomavirus (10) and simian virus 40 (11) , as well as the PreS1 protein ofhepadnaviruses (i.e., hepatitis B virus) (13) , are also modified by attachment of myristic acid and may influence nucleocapsid assembly and/or infectivity.
Myristoylation of p6Ov-src of Rous sarcoma virus is required for its stable association with cellular membranes and morphological transformation of cells (14, 15) . Similarly, myristoylation has been proposed to be an important factor in transformation by gag-onc fusion proteins with kinase activity (16, 17) . In addition, fatty acid modification of the gag precursor to the internal structural proteins of many mammalian retroviruses [Moloney murine leukemia virus (MoMLV), Mason-Pfizer monkey virus (MPMV), human T-cell leukemia virus types I and II, human immunodeficiency virus 1 (HIV-1), and simian immunodeficiency virus type I] has recently been described (1, (18) (19) (20) (21) (22) (23) . In cells infected by MoMLV (22) or MPMV (23) , myristoylation of the gag polypeptide is required for normal virion assembly and infectious particle production.
HIV, like other mammalian retroviruses, encodes a gag precursor, Pr55gag, which is normally processed by the viral protease to the major structural proteins found in the mature extracellular virus particle. Both Pr55gag and the matrix protein (p17), which is proteolytically cleaved from the N-terminal end of Pr55gag, are myristoylated (see Fig. 1 ) (24, 25) . Analysis of the amino acid sequence of these proteins from different HIV-1 isolates shows that the myristoylation acceptor is always an N-terminal glycine residue (26) (27) (28) . Furthermore, the Prl80gag-pol precursor, which contains gag proteins as well as the viral replicative enzymes [protease, reverse transcriptase (RT), and integrase], is probably also myristoylated. The current study examines the role of myristoylation of the structural gag polyprotein precursor Pr55gag of HIV-1 in virus replication. Our results show that addition of the myristate moiety is required for stable membrane association, proteolytic processing, and assembly of Pr55gag into infectious extracellular particles of HIV-1.
MATERIALS AND METHODS
Cell Lines. T-lymphoid cell lines H9 and Jurkat were provided by J. Hoxie and R. C. Gallo (National Cancer Institute). COS-1 and HeLa cell lines were obtained from the American Type Culture Collection.
DNA Clones. pGG1 contains a functional clone of HIV-1 and was previously designated pHXB2gpt2 (29) . Plasmid pAenv is a derivative of pGG1 constructed by digestion with the restriction endonucleases Sal I and Xho I, followed by treatment with T4 DNA ligase thus deleting the entire envelope gene of HIV-1 (nucleotides 5366-8474).
Mutagenesis. The glycine to alanine substitution was made with the 20-mer oligonucleotide GCTCTCGCAGCCATCTC-TCT using oligonucleotide-directed mutagenesis as described by Kunkel (30) . The resultant plasmid was designated pGA1 and the mutation was confirmed by the dideoxynucleotide chain-termination method for sequencing DNA (31) . Transfection. Cells were transfected by the calcium phosphate precipitation technique for gene transfer (32) . Stable transfectants were isolated by cotransfection of HeLa cells with either pGA1 or pGG1 and SFneo [similar to pSV2neo with the addition of the spleen focus-forming virus long terminal repeat (33) ]. Cell clones resistant to G418 (400 ,ug/ml, GIBCO) and positive by HIV-1 p24 ELISA (DuPont) were selected for protein studies.
Virus Assays. Cell supernatants were tested on various days posttransfection for virus-specific antigen using the p24 ELISA (sensitivity of 0.03 ng/ml). Both the major structural nucleocapsid protein of HIV-1, p24, and the p24-containing Pr55gag can be detected by this assay (unpublished observation). Virions were concentrated 10:1 from culture supernatants by polyethylene glycol precipitation (30% in 150 mM NaCl/0.1 mM phenylmethylsulfonyl fluoride), solubilized, and virus-associated RT activity was measured by [32P]TTP incorporation using a poly(rA)-oligo(dT) template (34 (36) and transferred by electroblotting to a nitrocellulose membrane. HIV-specific proteins were identified by a series of reactions with goat anti-human IgG conjugated with biotin and avidin conjugated with horseradish peroxidase (HRP) and the HRP substrate 4-chloro-1-naphthol. For immunoprecipitations, postnuclear supernatant containing -5 x 106 cpm or cell-free supernatant was precleared with 5 ,ul of normal human sera and protein A-Sepharose (Pharmacia) and then incubated with 5 ,u of HIV-1 antibody-positive serum for 8 hr at 4°C, and an additional 2 hr with 40 ,ul of protein A-Sepharose (50% in RIPA buffer). The beads were washed four times with RIPA buffer and once with 10 mM Tris HCI, pH 7.4/0.1 M NaCI. The pellet was resuspended in 50 ,lI of 2x SDS/PAGE sample buffer (10 mM Tris-HCI, pH 8.0/2% SDS/2% 2-mercaptoethanol) and boiled 5 min, and the eluted proteins were separated by SDS/PAGE. The gel was fixed in isopropanol (25%), acetic acid (10%), treated with En3Hance (New England Nuclear/DuPont), dried, and exposed to preflashed x-ray film (X-Omat AR, Kodak). Subcellular Fractionation. Cells were rinsed twice in phosphate-buffered saline (PBS), scraped, pelleted by centrifugation at 250 x g for 10 min, and resuspended in a solution containing 1 mM MgCI2, 10 mM Tris HCI (pH 7.4), 1 mM EDTA. Cells were then broken with 45 strokes of a Dounce homogenizer with a Teflon pestle and the nuclei and unbroken cells were removed by centrifugation for 10 min at 1000 x g after adjusting the final salt concentration to 0.15 M NaCI. The soluble cytosol fraction (S-100) was separated from the membrane fraction (P-100) by centrifugation for 30 min at 4°C in a type 50 Ti rotor at 45,000 rpm. The pellet (P-100) was resuspended in STE (0.15 M NaCI/10 mM Tris HCI, pH 7.4/1 mM EDTA) and a fraction was saved for immunoblot analysis. The remaining sample was adjusted to 1 M NaCl and centrifuged again at 45,000 rpm. The two new fractions were designated salt wash (high ionic strength) P-100(+) and S-100(+). The original fractions were designated P-100(-) and S-100(-) to indicate no change in ionic strength of the buffer.
RESULTS

Mutagenesis.
To investigate the role of myristoylation of Pr55gag in HIV assembly and replication, we used oligonucleotide-directed mutagenesis to change the codon for the myristoyl-acceptor glycine of Pr55gag to a codon for the nonacceptor alanine in pGG1, a functional clone of HIV-1 (Fig. 1) . The mutant clone was designated pGA1.
Biological Effect of Myristoylation Minus Mutation. The pGA1 mutant and the parent plasmid pGG1 were transfected into CD4-HeLa (Fig. 2) or COS-1 cells (not shown) using calcium phosphate coprecipitation (32) . On day 4 posttransfection, CD4' human lymphoid cells (H9) were added to allow propagation and amplification of infectious virus released from the transfected cells. The nonadherent H9 cells were removed from the adherent HeLa cells on day 8 and were maintained in culture for an additional 2 weeks. Virusspecific antigen production, as measured by p24 antigen ELISA, was detected in supernatant solutions from both pGG1 and pGA1 transfected cultures prior to the addition of the H9 cells (Fig. 2) . However, neither virus antigen nor RT activity could be detected in the H9 cultures after cocultivation with pGA1 transfected HeLa (Fig. 2) or COS-1 cells (not shown). In contrast, production of infectious HIV by the pGG1 transfected cells was readily identified by syncytia formation among the H9 cells, p24 soluble antigen production, and RT activity (Fig. 2) . The pGA1 defect could, however, be complemented in trans, by the gag-pol expression plasmid pAenv (Fig. 2) . Similar results were obtained after direct transfection of the CD4+ Jurkat cell line (data not shown). These results show that the glycine to alanine substitution at the N terminus of the gag polyprotein Pr55gag eliminates propagation of infectious HIV-1. To determine whether noninfectious particles were assembled and released from pGA1 transfected cells, culture supernatant was concentrated and then fractionated by buoyant density centrifugation through a linear sucrose gradient (Fig. 2 those expressed in the pGG1 transfected cells (Fig. 3) . The wild-type Pr55gag of HIV-1 was labeled with [3H]myristate (Fig. 3B, lanes 1 and 3) as has been shown (24, 25 (Fig. 3A, lane 2) or a mouse anti-p24 monoclonal antibody (not shown). Processing of the gag precursor Pr55gag to the virus capsid antigen p24 was detected in the pGG1 transfected cells (Fig. 3A, lanes 1 and  3) but not in the pGA1 transfected cells (Fig. 3A, lane 2) . Nonmyristoylated Pr55gag Is Not Processed in Vivo. We further investigated the fate of the nonmyristoylated HIV-1 gag precursor (myr-) in the pGA1 transfected cells in a pulse-chase experiment. Confluent monolayers of the transfected HeLa cells were metabolically labeled with [35S]_ methionine/cysteine for 8 hr. A fraction of the labeled cells was refed with complete medium and harvested for immunoprecipitation 0 and 24 hr later (Fig. 4A) . Cell-free supernatant solution was also harvested at the end of the chase period. Virus-specific proteins were immunoprecipitated, separated by SDS/PAGE, and detected by autoradiography. In the pGG1 transfected cells, processed p24 can be seen immediately after the 8-hr pulse (no chase) (Fig. 4A, pGG1 , lane a). After the 24-hr chase period (lane b), nearly complete disappearance of cell-associated precursor coincided with the appearance of the virion-associated major structural protein p24 (lane c). In contrast, only minimal turnover of Pr55gag, and no processed p24 in the pGA1 transfected cells was seen at the 24-hr time point (Fig. 4A, pGA1, between these possibilities, processing of myr' and myrPr55gag was compared in vitro using purified HIV protease. Extracts of selected HeLa cell clones expressing myr' pGG1 or myr-pGA1 Pr55gag were incubated with purified HIV protease (50 ng/ml) and the time-dependent proteolysis of Pr55gag was followed by immunoblot analysis of the cleavage products using a mouse monoclonal antibody to p24 (Fig. 5) 1-5, respectively) . The samples were precipitated with 10%o trichloroacetic acid, rinsed with acetone, solubilized in sample buffer, and separated on a 7.5-20%o gradient SDS/polyacrylamide gel. HIV-specific proteins were detected by immunoblot techniques using a mouse monoclonal antibody to p24 (Pr55gag, which contains p24, is also recognized). specific proteins in each fraction were identified by immunoblot detection (Fig. 4B) .
In the first set of experiments, HIV-specific proteins present in the cytosol or membrane fractions, prepared from pGG1, pGA1, and control (C) HeLa (Fig. 4B) (37) . Its identity was confirmed by immunologic detection using a monoclonal antibody to p24 (not shown). In the pGA1 cell line, this protein is not myristoylated (Fig. 3, lanes 2 ) and displays a cellular distribution similar to that of the myr-Pr55gag (Fig. 4B) Deletion of Gly-1 or mutagenesis of the Gly-1 to alanine in Pr65gag of MoMLV also blocked myristoylation (22) . The nonmyristoylated polyprotein failed to associate with the membrane fraction and virus particle formation was inhibited.
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Similarly, a Gly-1 to valine substitution in the MPMV Pr78gag polyprotein resulted in an accumulation of immature type A particles containing unprocessed precursor and prevented production of infectious virions (23) . A single point mutation present in the endogenous murine ecotropic provirus EMV-3 probably also accounts for the nonmyristolated gag polyprotein and the lack of infectious virus particles observed in vivo (38) . Taken together, these studies suggest that protein Nmyristoylation plays a central role in gag polyprotein association with a specific cellular membrane component where maturation and budding occurs. In this regard, we found that in the absence of the myristoyl moiety, Pr55gag was only weakly associated with the membrane fraction. In contrast, myristoylated Pr55gag was tightly bound. This suggests that assembly and budding of virus requires membrane targeting of Pr55gag and stable complex formation mediated, at least in part, by the myristoyl moiety. The activity of the virusencoded protease may also be dependent on the correct topographical association of its precursor molecule, Prl8M. Alternatively, failure to myristoylate this precursor might prevent dimerization-dependent autocatalytic release of the protease, the proposed mechanism for activation of the aspartyl protease (39) . Without the active protease and/or association with its specific substrate myr' Pr55gag, maturation and budding of HIV infectious particles cannot occur.
It is interesting to note that avian and certain mammalian retroviruses including two members of the lentivirus subfamily (visna and equine infectious anemia virus) and the human spumaretrovirus produce gag precursors that are not myristoylated (40, 41 ). An alternative mechanism of gag precursor localization and/or association with membranes in cells infected by these viruses is likely to be responsible but is currently uncharacterized.
Although it is possible that substitution or elimination of the N-terminal glycine residue could itself affect the processing of the gag polyprotein, our data demonstrating cleavage of the myr Pr55gag in vitro, using purified HIV protease, suggests that the defect in processing in transfected cell lines is a specific effect of the fatty acid moiety. In support of this conclusion, the inhibitor of de novo fatty acid synthesis, cerulenin, prevents myristoylation of Pr55gag of HIV-1 and its proteolytic cleavage to p24 (42) . In addition, the potential inhibitor of protein N-myristoylation, N-myristoyl glycinal diethylacetal, prevents myristoylation of pl7gag, the N-terminal component of Pr55gag, and may disrupt viral assembly (43) .
It may be possible to further examine the contribution of acyl chain hydrophobic character to the biological function(s) served by protein acylation by generating a family of fatty acid analogues that act as alternative acyltransferase substrates (44) . Also, radiolabeled analogues of myristic acid could potentially be used to analyze the intracellular steps involved in protein processing and targeting. The development of specific inhibitors of protein acylation that are active in vivo without substantial cellular toxicity would also be desirable given the importance of gag polyprotein myristoylation in human retrovirus replication (45) .
